Bangladesh Clinical Trials Limited (BCTL) is a newly established company jointly formed by icddr,b, an international health organization in Dhaka, and Mr. Md. Abdur Razzaq, a successful local entrepreneur.

BCTL aims to be the preferred research partner for pharmaceutical and biotechnology companies globally. icddr,b, with decades of experience, conducts credible clinical trials to assess the efficacy of drugs approved by Western regulatory authorities. They have high-quality laboratories, ISO certifications, biostatistics capacity, and an in-house Clinical Trial Unit.

Mr. Razzaq's conglomerate of 19 health-related businesses showcases his keen interest in improving medical services in Bangladesh. BCTL is fully financed by Mr.

Razzaq, who has committed up to US$ 1M over the next three years to support its operations. Their mission is to deliver scientific competence, excellence, and compliance with global regulations, offering comprehensive services to pharmaceutical, generic, and biotechnology companies. Since their establishment in January 2020, BCTL has gained approval as a Clinical Trial Centre/Contract Research Organization and shifted their focus to supporting international clients.

With integrity, quality, and customer excellence as their values, BCTL aims to shape the future of the clinical research industry. To get in touch, you can contact BCTL at their office in Dhaka, Bangladesh, or through their provided email and phone number